共 50 条
- [31] EFFECTIVENESS OF COMBINATION CISPLATIN-BASED INTRAVESICAL CHEMOTHERAPY FOR BCG-REFRACTORY BLADDER CANCER [J]. JOURNAL OF UROLOGY, 2020, 203 : E1124 - E1124
- [33] BCG IN THE TREATMENT OF SUPERFICIAL BLADDER-CANCER [J]. JOURNAL OF UROLOGY, 1987, 137 (04): : A180 - A180
- [34] BCG AND THE TREATMENT OF SUPERFICIAL BLADDER-CANCER [J]. DICP-THE ANNALS OF PHARMACOTHERAPY, 1991, 25 (12): : 1355 - 1367
- [35] BCG IN THE TREATMENT OF SUPERFICIAL CANCER OF THE BLADDER - A REVIEW [J]. MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY, 1993, 10 (1-2): : 31 - 36
- [36] BCG FOR THE TREATMENT OF SUPERFICIAL BLADDER-TUMORS [J]. PATHOLOGIE BIOLOGIE, 1994, 42 (10): : 981 - 981
- [38] PATHOLOGIC UPSTAGING AT THE TIME OF RADICAL CYSTECTOMY IS ASSOCIATED WITH WORSE RECURRENCE FREE SURVIVAL IN PATIENTS WITH BCG-REFRACTORY BLADDER CANCER [J]. JOURNAL OF UROLOGY, 2009, 181 (04): : 641 - 641
- [39] Phase II trial of continuous treatment with sunitinib in patients with high-risk (BCG-refractory) non-muscle invasive bladder cancer [J]. Investigational New Drugs, 2019, 37 : 1231 - 1238